StoneWise | 326 followers on LinkedIn. A technology company committed to accelerating novel drug discovery with artificial intelligence | StoneWise, founded in 2018, is a leading technology company dedicated to AI-driven novel drug discovery, and became a JLABS Singapore member company in 2024. Based on the GPT/Transformer framework and integrated with geometric deep learning algorithms, StoneWise has exclusively built a small-molecule drug design platform with a multimodal AI 3D molecular generation large model as the core. The company offers products and services for early-stage drug discovery to over 100 pharmaceutical enterprises and research institutions worldwide, covering molecular generation and design, customized model training, compound screening, and other related solutions.